Company news

MedinCell SA news in 2025

MedinCell SA's news releases, calls and decks from 2025, newest first.

View company

Medincell Publishes its Consolidated Half-Year Financial Results

December 9, 2025

Medincell: Videoconference and Publication of Half-year Financial Results, Tuesday, December 9, 2025

December 1, 2025

Medincell Management to Present at the 8th Annual Evercore Healthcare Conference and at the Piper Sandler 37th Annual Healthcare Conference

November 27, 2025

Medincell Awarded New Grant to Fight Malaria

November 24, 2025

Medincell Management to Participate in Fireside Chat at the Jefferies London Healthcare Conference 2025 (London - Nov. 17-20, 2025)

November 13, 2025

Medincell Appoints Dr Grace Kim, Chief Strategy Officer, U.S. Finance, to Advance into Next Stage of US Capital Growth

November 11, 2025

Medincell to Join MSCI World Small Cap Index, a Leading Global Benchmark

November 10, 2025

Medincell to Participate in the UBS Global Healthcare Conference (Palm Beach) and the Stifel Healthcare Conference (New-York)

November 6, 2025

Medincell to Participate in the 2025 Truist Securities Biopharma Symposium (New-York)

October 22, 2025

Medincell: FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder

October 10, 2025

FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder

October 10, 2025

Teva and Medincell’s Risperidone LAI Approved in Canada as LONGAVO®

September 23, 2025

Medincell Announces the Appointment of Dr. Sharon Mates, Dr. Charles Kunsch, and Dr. Pascal Touchon to Its Board of Directors

September 12, 2025

Medincell: UZEDY® Approved in South Korea Following Successful US Launch

September 10, 2025

Medincell to Present at the H.C. Wainwright 27th Global Investment Conference and Participate in the Morgan Stanley 23rd Global Healthcare Conference

September 5, 2025

Medincell: Reminder of the Participation Terms in the Combined General Meeting

September 3, 2025

Medincell: Notice of the 2025 Annual General Meeting Published

August 4, 2025

Medincell Announces the Availability of its 2024-25 Universal Registration Document including the Annual Financial and CSR Reports

July 30, 2025

Medincell Proposes Board Appointments of Industry Veterans Dr. Sharon Mates and Dr. Charles Kunsch

July 29, 2025

Medincell Publishes its Consolidated Annual Financial Results

June 17, 2025

Medincell to Present 2024-2025 Annual Results on June 17, 2025

June 10, 2025

Medincell Executives to Join Fireside Chat at Jefferies Global Healthcare Conference 2025

May 28, 2025

Truist Securities Initiates Medincell’s Coverage with a "Buy" Recommendation

May 28, 2025

Calls in 2025

Decks in 2025